Drug intelligence / Profile preview

Novel Pharmaceutical Drug

Development stage
Unknown
Lead developer
Evithé Biotechnology
Modality
Small Molecules
01

Overview

Novel Pharmaceutical Drug is an investigational plant-based therapeutic being developed by Evithé Biotechnology for the treatment of acute inflammation and as an antibiotic synergist. Currently in Phase 1 clinical development, the drug is part of a platform of novel plant-derived compounds designed to modulate key inflammatory and immune mediators. Its mechanism of action involves the inhibition or modulation of Tumor Necrosis Factor-alpha (TNF-α), Interleukin-6 (IL-6), and Nitric Oxide, as well as the modulation of immunoglobulin G (IgG) and immunoglobulin M (IgM) levels. By targeting these pathways, the drug aims to provide potent anti-inflammatory effects and enhance the efficacy of antibiotics, potentially addressing conditions where inflammation and bacterial resistance are significant challenges.

Other names
Novel Pharmaceutical Drug
02

Targets

IL-6 (Interleukin 6)IgM (Immunoglobulin M)TNFA (Tumor necrosis factor alpha (soluble))NOS2 (Nitric Oxide Synthase 2)

Beyond the preview

Go deeper on Novel Pharmaceutical Drug.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel Pharmaceutical Drug.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call